---
figid: PMC4712330__aging-07-1032-g004
figtitle: PTEN tumor suppressor gene and its role in lymphoma pathogenesis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Moloney murine leukemia virus
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4712330
filename: aging-07-1032-g004.jpg
figlink: /pmc/articles/PMC4712330/figure/F4/
number: F4
caption: PTEN deficiency is associated with increased sensitivity to PI3K, AKT, and
  mTOR inhibitors. In addition, because PI3K is involved in BCR signaling activation,
  BCR pathway inhibitors may also be effective in PTEN-deficient lymphoid malignancies.
  SRC family kinase inhibitors include dasatinib (which can also inhibit BTK), saracatinib,
  bosutinib, SU6656, CGP76030, and KX-01. BTK inhibitors include ibrutinib and AVL-292.
  Sotrastaurin is a PKCβ inhibitor; A20, a MALT1 paracaspase inhibitor; and MLN120B,
  an IKKβ inhibitor. SYK inhibitors include fostamatinib and PRT062607. Idelalisib
  is a PI3Kδ-specific inhibitor. MK-2206 is an AKT inhibitor. mTOR inhibitors include
  everolimus and temsirolimus.
papertitle: The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
reftext: Xiaoxiao Wang, et al. Aging (Albany NY). 2015 Dec;7(12):1032-1049.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9589238
figid_alias: PMC4712330__F4
figtype: Figure
redirect_from: /figures/PMC4712330__F4
ndex: b733c647-dee2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4712330__aging-07-1032-g004.html
  '@type': Dataset
  description: PTEN deficiency is associated with increased sensitivity to PI3K, AKT,
    and mTOR inhibitors. In addition, because PI3K is involved in BCR signaling activation,
    BCR pathway inhibitors may also be effective in PTEN-deficient lymphoid malignancies.
    SRC family kinase inhibitors include dasatinib (which can also inhibit BTK), saracatinib,
    bosutinib, SU6656, CGP76030, and KX-01. BTK inhibitors include ibrutinib and AVL-292.
    Sotrastaurin is a PKCβ inhibitor; A20, a MALT1 paracaspase inhibitor; and MLN120B,
    an IKKβ inhibitor. SYK inhibitors include fostamatinib and PRT062607. Idelalisib
    is a PI3Kδ-specific inhibitor. MK-2206 is an AKT inhibitor. mTOR inhibitors include
    everolimus and temsirolimus.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PHF11
  - PIK3AP1
  - SYK
  - BMX
  - EPHA3
  - PTEN
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PDK1
  - PDPK1
  - INPP5D
  - AKT1
  - AKT2
  - AKT3
  - CARD11
  - BCL10
  - TNFAIP3
  - IGKV1-27
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MTOR
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CD19
  - Syk
  - Pten
  - Prkcg
  - Pdk1
  - Akt1
  - Card11
  - Bcl10
  - Mtor
  - Nfkb1
  - Pik3cg
  - Cd19
  - Pik3ap1
  - Bmx
  - Pdpk1
  - Inpp5d
  - Tnfaip3
  - Pik3r1
  - Shark
  - Pec
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ca
  - Akt
  - IKKepsilon
  - key
  - IKKbeta
  - Tor
  - Dif
  - dl
  - Rel
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Bosutinib
  - CGP76030
  - Saracatinib
  - Fostamatinib
  - Sotrastaurin
  - MK-2206
  - Ibrutinib
  - PRT062607
  - Cancer
---
